Company / Operating Cash Flow per Share
FENNEC PHARMACEUTICALS INC. Operating Cash Flow per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.98
FY2025
5-year range
-$0.69 / $0.98
FY2021-FY2025
Trend
+254.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed +255% YoY in FY2025, a notable deviation from the 9-year average annual change of +11%.
Based on SEC 10-K filings.
0.98 in FY2025.
Improved from $-0.69 to $0.98 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 254.5% year-over-year.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.98 | +254.5% |
| FY2024 | -$0.63 | +7.4% |
| FY2023 | -$0.69 | -14.2% |
| FY2021 | -$0.60 | -52.5% |
| FY2019 | -$0.39 | -98.9% |
| FY2018 | -$0.20 | -27.0% |
| FY2017 | -$0.16 | +8.5% |
| FY2016 | -$0.17 | -6.1% |
| FY2015 | -$0.16 | +29.5% |
| FY2014 | -$0.23 | -91.1% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026